一种多价值个性化疫苗调节双信号激活,重建了先天性和自适应性抗瘤免疫之间的桥梁
Xiaorong Kou1, Tao He1, Miaomiao Zhang1
1Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, P. R. China.
布里奇-瓦克斯 (Bridge-Vax) 是一种新型的水凝疫苗,增强了对各种瘤抗原的CD8+T细胞免疫力. 这种方法克服了当前癌症疫苗的局限性,为个性化免疫疗法提供了强大的抗瘤反应和免疫记忆.
科学领域:
- 生物技术是生物技术.
- 免疫学 免疫学 免疫学
- 材料科学 材料科学 材料科学
背景情况:
- 个性化疫苗显示出对瘤异质性的承诺,但面临的挑战是有限的抗原和弱的CD8+T细胞反应.
- 目前的策略往往无法引起强大和全面的抗瘤免疫力,从而阻碍治疗疗效.
研究的目的:
- 设计一种基于水凝的新型疫苗 (Bridge-Vax),可以弥合先天性和适应性免疫力,以激活CD8+T细胞对抗全谱瘤抗原.
- 增强树突细胞 (DC) 激活和抗原交叉呈现,用于强大的CD8+T细胞反应.
主要方法:
- 开发一种双信号合调交联水凝疫苗 (Bridge-Vax),其中包含颗粒细胞-巨细胞殖民地刺激因子和simvastatin.
- 利用自身瘤细胞膜作为个性化疫苗配方的抗原.
- 在体内B16-OVA和B16F10瘤模型中评估疫苗的疗效.
主要成果:
- 布里奇-瓦克斯有效缩和激活树突细胞 (DCs),通过共刺激信号和增强的MHC-I交叉呈现促进T细胞激活.
- 该疫苗引起强大的抗原特异性CD8+T细胞反应,在减少瘤生长和建立长期免疫记忆方面表现出有效性.
- 在B16F10模型中,个性化的多价值布里奇-瓦克斯配方抑制了术后瘤复发.
结论:
- 桥-瓦克斯是一种简单的策略,可以重建先天性和适应性免疫桥梁,诱导强大的CD8+T细胞免疫力.
- 这个平台为个性化癌症免疫治疗提供了一个强大的工具,解决了当前疫苗方法的局限性.
更多相关视频
10:18Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
Published on: July 7, 2023
08:02In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
Published on: September 23, 2021
相关概念视频
Tumor Immunotherapy
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
